Canada markets closed

Singular Genomics Systems, Inc. (OMIC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4131+0.0131 (+3.27%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 30.60M
Enterprise Value -68.06M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)10.33
Price/Book (mrq)0.17
Enterprise Value/Revenue -23.38
Enterprise Value/EBITDA 0.79

Trading Information

Stock Price History

Beta (5Y Monthly) 1.40
52-Week Change 3-61.90%
S&P500 52-Week Change 322.38%
52 Week High 31.2100
52 Week Low 30.3100
50-Day Moving Average 30.4854
200-Day Moving Average 30.4779

Share Statistics

Avg Vol (3 month) 3113.47k
Avg Vol (10 day) 383.44k
Shares Outstanding 574.07M
Implied Shares Outstanding 674.07M
Float 846.55M
% Held by Insiders 113.96%
% Held by Institutions 148.23%
Shares Short (Apr 15, 2024) 4603.25k
Short Ratio (Apr 15, 2024) 46.09
Short % of Float (Apr 15, 2024) 41.01%
Short % of Shares Outstanding (Apr 15, 2024) 40.81%
Shares Short (prior month Mar 15, 2024) 4813.51k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,338.67%

Management Effectiveness

Return on Assets (ttm)-21.25%
Return on Equity (ttm)-43.17%

Income Statement

Revenue (ttm)2.91M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)41.30%
Gross Profit (ttm)N/A
EBITDA -97.39M
Net Income Avi to Common (ttm)-94.82M
Diluted EPS (ttm)-1.3000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)175.4M
Total Cash Per Share (mrq)2.37
Total Debt (mrq)75.29M
Total Debt/Equity (mrq)42.06%
Current Ratio (mrq)10.51
Book Value Per Share (mrq)2.42

Cash Flow Statement

Operating Cash Flow (ttm)-73.65M
Levered Free Cash Flow (ttm)-36.81M